Literature DB >> 32126270

Brain microRNAs dysregulation: Implication for missplicing and abnormal post-translational modifications of tau protein in Alzheimer's disease and related tauopathies.

Maryam Bazrgar1, Pariya Khodabakhsh2, Fatemeh Mohagheghi3, Mercedes Prudencio4, Abolhassan Ahmadiani5.   

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs that regulate post-transcriptional gene expression by targeting specific mRNAs for degradation or translation repression. Changes in miRNAs expression profiles have been reported in several neurodegenerative disorders such as Alzheimer's disease (AD) and related tauopathies, which are characterized by tau aggregation and neurofibrillary tangle formation (NFTs) in the brain. There is a fundamental challenge in determining how dysregulation of miRNAs can promote a pathological condition. Therefore, identifying the target genes of dysregulated miRNAs, signaling pathways and biological processes, as well as pathogenic factors which trigger miRNA dysregulation may be helpful for subsequent therapeutic development. This article reviews studies focused on the presently known roles of miRNAs in the regulation of alternative splicing and post-translational modifications of tau, events associated with the development of AD and related tauopathies. We hope this review will help readers understand the pathogenesis and the most recent therapeutic approaches to treat tauopathies.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alternative splicing; Alzheimer’s disease; Post-translational modifications; Tau protein; Tauopathies; miRNA

Mesh:

Substances:

Year:  2020        PMID: 32126270     DOI: 10.1016/j.phrs.2020.104729

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  7 in total

1.  Lactoferrin modification of berberine nanoliposomes enhances the neuroprotective effects in a mouse model of Alzheimer's disease.

Authors:  Lin Wang; Bi-Qiang Zhou; Ying-Hong Li; Qian-Qian Jiang; Wei-Hong Cong; Ke-Ji Chen; Xiao-Min Wen; Zheng-Zhi Wu
Journal:  Neural Regen Res       Date:  2023-01       Impact factor: 6.058

Review 2.  Extracellular Vesicles Loaded miRNAs as Potential Modulators Shared Between Glioblastoma, and Parkinson's and Alzheimer's Diseases.

Authors:  Laura Thomas; Tullio Florio; Carolina Perez-Castro
Journal:  Front Cell Neurosci       Date:  2020-11-04       Impact factor: 5.505

3.  Implications of miR-148a-3p/p35/PTEN signaling in tau hyperphosphorylation and autoregulatory feedforward of Akt/CREB in Alzheimer's disease.

Authors:  Li Zeng; Hailun Jiang; Ghulam Md Ashraf; Jianghong Liu; Linlin Wang; Kaiyue Zhao; Mimin Liu; Zhuorong Li; Rui Liu
Journal:  Mol Ther Nucleic Acids       Date:  2021-11-29       Impact factor: 8.886

Review 4.  Tau mRNA Metabolism in Neurodegenerative Diseases: A Tangle Journey.

Authors:  Paulo J da Costa; Malika Hamdane; Luc Buée; Franck Martin
Journal:  Biomedicines       Date:  2022-01-23

5.  miR-143-3p Inhibits Aberrant Tau Phosphorylation and Amyloidogenic Processing of APP by Directly Targeting DAPK1 in Alzheimer's Disease.

Authors:  Long Wang; Xindong Shui; Yingxue Mei; Yongfang Xia; Guihua Lan; Li Hu; Mi Zhang; Chen-Ling Gan; Ruomeng Li; Yuan Tian; Quling Wang; Xi Gu; Dongmei Chen; Tao Zhang; Tae Ho Lee
Journal:  Int J Mol Sci       Date:  2022-07-20       Impact factor: 6.208

Review 6.  The Functional Role of microRNAs in the Pathogenesis of Tauopathy.

Authors:  Domenico Praticò
Journal:  Cells       Date:  2020-10-09       Impact factor: 6.600

7.  MicroRNAs Modulate the Pathogenesis of Alzheimer's Disease: An In Silico Analysis in the Human Brain.

Authors:  Agnese Gugliandolo; Luigi Chiricosta; Virginia Boccardi; Patrizia Mecocci; Placido Bramanti; Emanuela Mazzon
Journal:  Genes (Basel)       Date:  2020-08-24       Impact factor: 4.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.